AGTC to Present at the OIS Gene Therapy Innovation Showcase on February 18, 2021GlobeNewsWire • 02/16/21
AGTC to Present at the 4th Annual Gene Therapy for Rare Disorders Digital Event, February 22-25, 2021GlobeNewsWire • 02/16/21
Applied Genetic Technologies: Leader Among Larger Peers In Gene Therapies For Certain Eye DiseasesSeeking Alpha • 02/16/21
Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/11/21
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2020GlobeNewsWire • 02/11/21
AGTC Executives Awarded First Place in the BioProcess International Reader's Choice Awards, Cell & Gene Therapies CategoryGlobeNewsWire • 02/04/21
AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 11, 2021GlobeNewsWire • 02/04/21
AGTC Announces First Reported Improvements in Visual Sensitivity for Achromatopsia (ACHM) patients from its Ongoing Clinical TrialsGlobeNewsWire • 01/27/21
Applied Genetic Technologies (AGTC) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 11/16/20
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2020GlobeNewsWire • 11/16/20
AGTC Reports Additional Positive Data from its Phase 1/2 Clinical Trial in Patients with X-Linked Retinitis PigmentosaGlobeNewsWire • 11/11/20
AGTC to Host Conference Call on November 11 at 8:00 am ET to Discuss XLRP 12-Month Data and Full 6-Month Data from Highest Dose Groups of its Ongoing Phase 1/2 Clinical TrialGlobeNewsWire • 11/10/20
AGTC to Participate in Cantor Fitzgerald Virtual Panel: Key Considerations for Gene Therapy Manufacturing and PlatformsGlobeNewsWire • 10/21/20
Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 09/09/20
AGTC Provides Trial Design Update for its Phase 2/3 XLRP Clinical Trial, New Data on XLRP Higher Dose Group and Financial Results for the Fourth Quarter and Year Ended June 30, 2020GlobeNewsWire • 09/09/20
AGTC Announces Publication of Preclinical Data that Support the Ongoing Clinical Development of Its XLRP Gene Therapy ProgramGlobeNewsWire • 08/25/20
AGTC Formalizes Patient Advisory Council to Provide Insights and Guidance on Patient Perspectives for Pipeline TherapiesGlobeNewsWire • 08/12/20